Literature DB >> 23973362

Identification of neuropathic pain in patients with neck/upper limb pain: application of a grading system and screening tools.

Brigitte Tampin1, Noelle Kathryn Briffa, Roger Goucke, Helen Slater.   

Abstract

The Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain has proposed a grading system for the presence of neuropathic pain (NeP) using the following categories: no NeP, possible, probable, or definite NeP. To further evaluate this system, we investigated patients with neck/upper limb pain with a suspected nerve lesion, to explore: (i) the clinical application of this grading system; (ii) the suitability of 2 NeP questionnaires (Leeds Assessment of Neuropathic Symptoms and Signs pain scale [LANSS] and the painDETECT questionnaire [PD-Q]) in identifying NeP in this patient cohort; and (iii) the level of agreement in identifying NeP between the NeuPSIG classification system and 2 NeP questionnaires. Patients (n = 152; age 52 ± 12 years; 53% male) completed the PD-Q and LANSS questionnaire and underwent a comprehensive clinical examination. The NeuPSIG grading system proved feasible for application in this patient cohort, although it required considerable time and expertise. Both questionnaires failed to identify a large number of patients with clinically classified definite NeP (LANSS sensitivity 22%, specificity 88%; PD-Q sensitivity 64%, specificity 62%). These lowered sensitivity scores contrast with those from the original PD-Q and LANSS validation studies and may reflect differences in the clinical characteristics of the study populations. The diagnostic accuracy of LANSS and PD-Q for the identification of NeP in patients with neck/upper limb pain appears limited.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical assessment; LANSS; Neuropathic pain; Pain questionnaire; painDETECT

Mesh:

Year:  2013        PMID: 23973362     DOI: 10.1016/j.pain.2013.08.018

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

1.  Effect of Neural Mobilization on Nerve-Related Neck and Arm Pain: A Randomized Controlled Trial.

Authors:  Cato Annalie Basson; Aimee Stewart; Witness Mudzi; Eustasius Musenge
Journal:  Physiother Can       Date:  2020-11-01       Impact factor: 1.037

2.  Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study.

Authors:  Bryan J Moreton; Victoria Tew; Roshan das Nair; Maggie Wheeler; David A Walsh; Nadina B Lincoln
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-04       Impact factor: 4.794

3.  Measurement properties of painDETECT: Rasch analysis of responses from community-dwelling adults with neuropathic pain.

Authors:  Tara L Packham; Joseph C Cappelleri; Alesia Sadosky; Joy C MacDermid; Florian Brunner
Journal:  BMC Neurol       Date:  2017-03-04       Impact factor: 2.474

4.  Avoiding Catch-22: validating the PainDETECT in a in a population of patients with chronic pain.

Authors:  Hans Timmerman; André P Wolff; Ewald M Bronkhorst; Oliver H G Wilder-Smith; Marcel J Schenkels; Nick T van Dasselaar; Frank J P M Huygen; Monique A H Steegers; Kris C P Vissers
Journal:  BMC Neurol       Date:  2018-06-29       Impact factor: 2.474

Review 5.  Tapentadol for neuropathic pain: a review of clinical studies.

Authors:  Ulderico Freo; Patrizia Romualdi; Hans G Kress
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

6.  Can Urine Metabolomics Be Helpful in Differentiating Neuropathic and Nociceptive Pain? A Proof-of-Concept Study.

Authors:  Gabriele Finco; Emanuela Locci; Paolo Mura; Roberta Massa; Antonio Noto; Mario Musu; Giovanni Landoni; Ernesto d'Aloja; Fabio De-Giorgio; Paola Scano; Maurizio Evangelista
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

7.  The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey.

Authors:  Marco D DiBonaventura; Alesia Sadosky; Kristen Concialdi; Markay Hopps; Ian Kudel; Bruce Parsons; Joseph C Cappelleri; Patrick Hlavacek; Andrea H Alexander; Brett R Stacey; John D Markman; John T Farrar
Journal:  J Pain Res       Date:  2017-11-01       Impact factor: 3.133

8.  Investigating the validity of the DN4 in a consecutive population of patients with chronic pain.

Authors:  Hans Timmerman; Monique A H Steegers; Frank J P M Huygen; Jelle J Goeman; Nick T van Dasselaar; Marcel J Schenkels; Oliver H G Wilder-Smith; André P Wolff; Kris C P Vissers
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

9.  Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam.

Authors:  Ian Kudel; Markay Hopps; Joseph C Cappelleri; Alesia Sadosky; Kristen King-Concialdi; Ryan Liebert; Bruce Parsons; Patrick Hlavacek; Andrea H Alexander; Marco D DiBonaventura; John D Markman; John T Farrar; Brett R Stacey
Journal:  J Pain Res       Date:  2019-01-07       Impact factor: 3.133

10.  Comparison of 2 methods of neuropathic pain assessment in carpal tunnel syndrome and hand functions.

Authors:  Esma Ceceli; Sefa Gumruk; Muyesser Okumus; Seher Kocaoglu; Hamit Goksu; Aynur Karagoz
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.